Why is GE HealthCare acquiring Sofie Biosciences for PET drug logistics?

GE HealthCare is buying Sofie Biosciences for $945 million to expand its radiopharmaceutical manufacturing and distribution capabilities, especially for time-sensitive PET imaging drugs. The deal is framed as a scale and logistics move, aimed at improving reliability, reach, and supply close to the point of care.